Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis
暂无分享,去创建一个
A. Burroughs | S. Bonhoeffer | M. Johnson | P. Griffiths | V. Emery | R. Regoes | P. Sweny | A. Cope | A. Hassan-Walker | H. Grant Prentice | D. Gor | E. Frances Bowen
[1] Louis J. Picker,et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.
[2] G. Carcelain,et al. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease , 2005, The Journal of experimental medicine.
[3] R. Hetzer,et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells , 2005, The Journal of experimental medicine.
[4] D. Baarle,et al. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells. , 2005, Immunology letters.
[5] F. Miedema,et al. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. , 2005, The Journal of infectious diseases.
[6] C. Sabin,et al. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy , 2004, The Lancet.
[7] H. Ploegh,et al. A membrane protein required for dislocation of misfolded proteins from the ER , 2004, Nature.
[8] E. Mocarski. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. , 2002, Trends in microbiology.
[9] H. Ploegh,et al. The Human Cytomegalovirus US8 Glycoprotein Binds to Major Histocompatibility Complex Class I Products , 2002, Journal of Virology.
[10] Andrew K Burroughs,et al. Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. , 2002, The Journal of infectious diseases.
[11] H. Ploegh,et al. Human Cytomegalovirus Gene Products US2 and US11 Differ in Their Ability To Attack Major Histocompatibility Class I Heavy Chains in Dendritic Cells , 2002, Journal of Virology.
[12] P. Griffiths,et al. Definitions of cytomegalovirus infection and disease in transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[14] S. Staprans,et al. Contribution of Peaks of Virus Load to Simian Immunodeficiency Virus Pathogenesis , 2002, Journal of Virology.
[15] H. Ploegh,et al. Human Cytomegalovirus Open Reading Frame TRL11/IRL11 Encodes an Immunoglobulin G Fc-Binding Protein , 2001, Journal of Virology.
[16] L. Schmetterer,et al. Ocular blood flow in patients infected with human immunodeficiency virus. , 2001, American journal of ophthalmology.
[17] W. Cumberland,et al. Decreased macular leukocyte velocity in human immunodeficiency virus-infected individuals. , 2001, American journal of ophthalmology.
[18] R. Laufs,et al. Area under the viraemia curve versus absolute viral load: Utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients , 2001, Journal of medical virology.
[19] V. Emery,et al. Investigation of CMV disease in immunocompromised patients , 2001, Journal of clinical pathology.
[20] A. Limaye,et al. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. , 2001, The Journal of infectious diseases.
[21] G. Janossy,et al. Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited , 2000, Bone Marrow Transplantation.
[22] J. Bell,et al. Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors , 2000, Journal of Virology.
[23] C. Sabin,et al. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation , 2000, The Lancet.
[24] W. G. Nichols,et al. Recent advances in the therapy and prevention of CMV infections. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[25] C. Sabin,et al. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group , 1999, The Journal of infectious diseases.
[26] Vincent C. Emery,et al. The Dynamics of Human Cytomegalovirus Replication in Vivo , 1999, The Journal of experimental medicine.
[27] C. Sabin,et al. Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: Relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG) , 1999, Journal of medical virology.
[28] A. Minguela,et al. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. , 1998, Transplantation.
[29] C. Sabin,et al. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease , 1998, Bone Marrow Transplantation.
[30] S. Spector,et al. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. , 1998, The Journal of clinical investigation.
[31] C. Sabin,et al. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. , 1997, The Journal of infectious diseases.
[32] C. Sabin,et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV‐positive patients at high risk of CMV disease , 1997, AIDS.
[33] F. Ognibene,et al. Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection. , 1997, American journal of respiratory and critical care medicine.
[34] S. Spector,et al. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. , 1997, The Journal of infectious diseases.
[35] J. Phair,et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. , 1996, Archives of ophthalmology.
[36] P. Griffiths,et al. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. , 1995, The Journal of general virology.
[37] M. Ho. Advances in understanding cytomegalovirus infection after transplantation. , 1994, Transplantation proceedings.
[38] S. Riddell,et al. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes , 1994, Journal of medical virology.
[39] P. Griffiths,et al. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. , 1992, The Journal of general virology.
[40] P. Griffiths,et al. Severe cytomegalovirus pneumonitis in HIV infected patients with higher than average CD4 counts. , 1992, Thorax.
[41] T. Shenk,et al. Manipulation of the cell cycle by human cytomegalovirus. , 2002, Frontiers in bioscience : a journal and virtual library.
[42] H. Ploegh,et al. Viral subversion of the immune system. , 2000, Annual review of immunology.
[43] D. Jabs,et al. Cytomegalovirus retinitis in AIDS: natural history, diagnosis, and treatment. , 1995, AIDS clinical review.